The present invention provides a process for the expoxidation of a protected 3-methylene-(trans)-1,2,-hydroxymethylcyclopropane with cyclohexanone and potassium peroxymonosulfate and subsequent rearrangement to provide the corresponding cyclobutanone.
Process For Preparing Chiral Diol Sulfones And Dihydroxy Acid Hmg Coa Reductase Inhibitors
A process is provided for preparing chiral diol sulfones of the structure where Ris preferably where Ris preferably aryl such as phenyl, and Ris preferably alkyl such as t-butyl, which are intermediates used in preparing HMG CoA reductase inhibitors.
Process For Preparing Chiral Diol Sulfones And Dihydroxy Acid Hmg Coa Reductase Inhibitors
A process is provided for preparing chiral diol sulfones of the structure where Ris preferably where Ris preferably aryl such as phenyl, and Ris preferably alkyl such as t-butyl, which are intermediates used in preparing HMG CoA reductase inhibitors.
Steven P. Brundidge - Wolcott NY Paul R. Brodfuehrer - Syracuse NY Chet Sapino - East Syracuse NY Kun M. Shih - East Syracuse NY Donald G. Walker - Liverpool NY
Assignee:
Bristol-Myers Company - New York NY
International Classification:
C07D50146 A61K 31545
US Classification:
540222
Abstract:
Processes for the preparation of stable, crystalline cephalosporin intermediates of the formula ##STR1## wherein X is HI or HCl, and Nu and Nu. sup. sym. are certain N-containing heterocyclic rings attached via a sulfur atom or a ring nitrogen atom, respectively, which are substantially free of the. DELTA. sup. 2 isomer; processes for intermediates in the preparation of the above compounds; and processes for the preparation of broad-spectrum cephalosporin antibiotics.
Steven P. Brundidge - Wolcott NY Paul R. Brodfuehrer - Syracuse NY Chet Sapino - East Syracuse NY Kun M. Shih - East Syracuse NY Donald G. Walker - Liverpool NY
Assignee:
Bristol-Myers Company - New York NY
International Classification:
C07D50118
US Classification:
540222
Abstract:
Stable, crystalline cephalosporin intermediates of the formula ##STR1## wherein X is HI or HCl and Nu and Nu. sup. sym. are certain N-containing heterocyclic rings attached via a sulfur atom or a ring nitrogen atom, respectively, which are substantially free of the. DELTA. sup. 2 isomer; processes for, and intermediates in, the preparation of the above compounds; and processes for the preparation of broad-spectrum cephalosporin antibiotics.
Preparation And Use Of 7-[(2-Carboalkoxy-1-Methylethenyl)Amino]-3-Hydroxymethyl-3-Cephem-4-Carb Oxylic Acids
J. Gregory Reid - Manlius NY Paul R. Brodfuehrer - Syracuse NY Patrick R. Smith - Syracuse NY
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07D50118
US Classification:
540217
Abstract:
This invention relates to a method of producing 3-alkanoyloxymethyl-3-cephem-4-carboxylic acids from 3-hydroxymethyl-3-cephem-4-carboxylic acids in an aqueous medium for a practical, large-scale production. Moreover, the invention provides an ideal intermediate for the process.
Preparation And Use Of 7-[(2-Carboalkoxy-1-Methylethenyl)Amino]-3-Hydroxymethyl-3-Cephem-4-Carb Oxylic Acids
J. Gregory Reid - Manlius NY Paul R. Brodfuehrer - Syracuse NY Patrick R. Smith - Syracuse NY
Assignee:
Briston-Myers Squibb Company - Princeton NY
International Classification:
E07D50128
US Classification:
540230
Abstract:
This invention relates to a method of producing 3-alkanoyloxymethyl-3-cephem-4-carboxylic acids from 3-hydroxymethyl-3-cephem-4-carboxylic acids in an aqueous medium for a practical, large-scale production. Moreover, the invention provides an ideal intermediate for the process.
Dideoxyinosine By Enzymatic Deamination Of Dideoxyadenosine
Vittorio Farina - West Hartford CT Daniel A. Benigni - Elbridge NY Paul R. Brodfuehrer - Syracuse NY
Assignee:
Bristol-Myers Squibb Co. - New York NY
International Classification:
C12P 1938 C12P 1940 C12N 996 C12N 978
US Classification:
435 87
Abstract:
A novel process utilizing adenosine deaminase to selectively produce. beta. -(D)-2',3'-dideoxyinosine in high yields from an. alpha. ,. beta. -anomeric mixture. . beta. -(D)-2',3'-Dideoxyinosine so produced is useful as an antiviral and antibiotic agent.
Rensselaer Polytechnic Institute
Senior Process Chemist
Amri (Albany Molecular Research Inc.) Feb 2005 - Jul 2016
Project Manager at Amri
Bristol-Myers Squibb Complany 1983 - 2004
Group Leader, Chemical Development , Technical Operations
Bristol-Myers Squibb 1983 - 2004
Group Leader, Chemical Development
Skills:
Pharmaceutical Industry Technology Transfer Gmp Organic Chemistry Chemistry Drug Discovery Hplc Validation Analytical Chemistry Biotechnology Chemical Engineering Cro R&D Fda Drug Development Manufacturing Process Simulation Project Management V&V